Patents by Inventor Fabrice Jourdan

Fabrice Jourdan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Compound
    Patent number: 8394825
    Abstract: The present invention involves tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth.
    Type: Grant
    Filed: March 27, 2008
    Date of Patent: March 12, 2013
    Assignee: Sterix Limited
    Inventors: Matthew Leese, Fabrice Jourdan, Meriel Kimberley, Atul Purohit, Barry Victor Lloyd Potter, Gillian Reed
  • Oestrogen derivatives as inhibitors of steroid sulphatase
    Patent number: 7893284
    Abstract: The present invention provides a compound comprising a steroidal ring system and an optional group R1 selected from any one of —OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the D ring of the steroidal ring system is substituted by a group R2 of the formula -L-R3, wherein L is an optional linker group and R3 is selected from groups which are or which comprise one of a nitrite group, an alcohol, an ester, an ether, an amine and an alkene, provided that when R3 is or comprises an alcohol, L is present; and wherein the A ring of the steroidal ring system is substituted at position 2 or 4 with a group R4, wherein R4 is a hydrocarbyl group.
    Type: Grant
    Filed: September 23, 2005
    Date of Patent: February 22, 2011
    Assignee: Sterix Limited
    Inventors: Matthew Leese, Atul Purohit, Michael John Reed, Simon Paul Newman, Surinder Kuman Chander, Fabrice Jourdan, Barry Victor Lloyd Potter
  • COMPOUND
    Publication number: 20100222299
    Abstract: The present invention involves tetrahydroisoquinoline compounds and their use in the inhibition and/or prevention of tumor growth.
    Type: Application
    Filed: March 27, 2008
    Publication date: September 2, 2010
    Applicant: Sterix Limited
    Inventors: Fabrice Jourdan, Meriel Kimberley, Matthew Leese, Barry Victor Lloyd Potter, Atul Purohit, Michael John Reed
  • Microcin B17 Analogs And Methods For Their Preparation And Use
    Publication number: 20080234132
    Abstract: The present invention pertains to synthetic analogues of microcin B17 component units, methods of making and using these analogues, including, for example, as inhibitors of DNA gyrase.
    Type: Application
    Filed: November 18, 2005
    Publication date: September 25, 2008
    Inventors: Laurence Coquin, Fabrice Jourdan, Olivier Pierrat, David John Lowe, Anthony Maxwell, Christopher John Pickett, Melisa Wall
  • COMPOUND
    Publication number: 20070225256
    Abstract: The present invention provides a compound comprising a steroidal ring system and an optional group R1 selected from any one of —OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the A ring of the steroidal ring system is optionally substituted at position 2 or 4 with a group R4 which may be a suitable subtituent, wherein the D ring of the steroidal ring system is substituted by a group R2 of the formula -L-R3, wherein L is an optional linker group and R3 is selected from groups which are or which comprise one of (i) —SO2R5, wherein R5 is H, a hydrocarbyl group or a bond or group attached to the D ring; (ii) —NO2; (iii) —SOR6, wherein R6 is H or a hydrocarbyl group; (iv) —R7, wherein R7 is a halogen; (v) -alkyl; (vi) —C(?O)R3, wherein R3 is H or hydrocarbyl; (vii) —C?CR9, wherein R9 is H or hydrocarbyl; (viii) —OC(?O)NR10R11 wherein R10 and R11 are independently selected from H and hydrocarbyl; (ix), (x), (xi), (xii) and (xiii) are formula
    Type: Application
    Filed: March 22, 2007
    Publication date: September 27, 2007
    Inventors: Matthew Leese, Atul Purohit, Michael Reed, Fabrice Jourdan, Barry Victor Potter, Christian Bubert
  • Oestrogen derivatives as inhibitors of steroid sulphatase
    Publication number: 20060094696
    Abstract: The present invention provides a compound comprising a steroidal ring system and an optional group R1 selected from any one of —OH, a sulphamate group, a phosphonate group, a thiophosphonate group, a sulphonate group or a sulphonamide group; wherein the D ring of the steroidal ring system is substituted by a group R2 of the formula -L-R3, wherein L is an optional linker group and R3 is selected from groups which are or which comprise one of a nitrite group, an alcohol, an ester, an ether, an amine and an alkene, provided that when R3 is or comprises an alcohol, L is present; and wherein the A ring of the steroidal ring system is substituted at position 2 or 4 with a group R4, wherein R4 is a hydrocarbyl group.
    Type: Application
    Filed: September 23, 2005
    Publication date: May 4, 2006
    Inventors: Mathew Leese, Alan Purohit, Michael Reed, Simon Newman, Surinder Chander, Fabrice Jourdan, Barry Potter